Brief news reports on Tuberculosis

North Korea struggling to fight epidemic of drug-resistant TB

North Korea is grappling with a strain of the deadly lung disease tuberculosis that is resistant to conventional treatment. Humanitarian workers say the impoverished communist country, which already has one of the highest rates of tuberculosis outside of sub-Saharan Africa, is unable to cope with the outbreak.  Most victims could die of the disease within years. But some help is coming from an outside foundation.

Read More →

Poor adherence not enough to cause development of MDR-TB

Poor adherence may not be enough to cause multidrug-resistant tuberculosis, a laboratory study published in the online edition of the Journal of Infectious Diseases suggests.

Read More →

XPert MTB/RIF found to be cost effective in low- and middle-income settings

A study led by Frank Cobelens of the Amsterdam Institute of Global Health and Development, Amsterdam, The Netherlands and colleagues reports on the cost-effectiveness of implementing the Xpert MTB/RIF diagnostic test for tuberculosis (TB) in high burden countries. Based on their findings, which are published in this week's PLoS Medicine, the authors predict that Xpert will be a cost-effective method of TB diagnosis, compared with current standard techniques, in low- and middle-income countries.

Read More →

ECDC: 80,000 cases of TB infection a year in Europe

Europe's health is suffering, with around 80,000 cases of tuberculosis infection a year and serious problems with measles, HIV and threats from "superbug" infections, an annual health report on the region said Thursday.

Read More →

New agreement to speed development of TB drug combinations

• AstraZeneca, Bayer, Sanofi, Tibotec, TB Alliance, and the World Health Organization sign partnership to share information on TB drugs in development
• FDA’s Dr. Janet Woodcock keynotes CPTR Workshop and highlights the need for regulatory science to advance regimen development for life-threatening diseases.

Read More →

China works to tackle TB/HIV

The 17th Core Group Meeting of the TB/HIV Working Group kicked off in Beijing China with opening remarks from Dr. Yu Jingin, director of the Disease Control Bureau of the China Ministry of Health, and Dr. Wang You, director of the China Centers for Disease Control (CDC).

Read More →

Weakest link in war against TB: Community participation

Around one third of the world population is estimated to be infected with the TB bacterium and is at risk of developing the disease. There were 8.8 million new cases of TB in 2010 and the disease killed a staggering 1.4 million people.

Read More →

South Africa: 'I would rather have HIV than TB'

"Which disease would you rather have: HIV or TB? I would rather have HIV," Professor Francois Venter from the Wits Reproductive Health and HIV Institute told a stunned audience at the recent 42nd Union World Conference on Lung Health held in Lille, France.

Read More →

Botswana hosts Africa HIV/TB drug resistance workshop

The two-day workshop started yesterday at the University of Botswana (UB). Scientists, public health officials and physicians from across the world are attending the event to discuss the growing problem of HIV and TB drug resistance in Southern Africa.

Read More →

Delayed Global Fund money a sign of economic times

Lille — The Global Fund to Fight HIV, TB and Malaria has more than halved the estimated amount of money available in its next round of funding, the disbursement of which has been delayed until 2013, due to the world economic crisis.

Read More →

Page 674 of 693 · Total posts: 10

←First 673 674 675 Last→